CTI Life Sciences Fund

CTI Life Sciences Fund

A venture capital firm in Canada that focuses on pharmaceutical development

CTI Life Sciences Fund is a venture capital firm in Canada that focuses on pharmaceutical development. Founded 2006 in Montréal, Quebec, Canada, it invests in series A, series B, series C, and venture rounds. Its portfolio companies include Visterra, PreciThera, PHEMI Health Systems, SutroVax, CellAegis Devices, ILKOS Therapeutic, IMV Inc, DalCor Pharmaceuticals, and Zymeworks. As of February 2020, CTI Life Sciences Fund has made 23 investments. Their most recent investment was on October 5, 2017, when Visterra raised $23.6M. CTI Life Sciences Fund has had seven exits, the most notable of which include Zymeworks, Visterra, and Medicago. The company has raised two funds, their latest being CTI Life Sciences Fund II. This fund was announced on January 15, 2015 and raised a total of $134M.

Timeline

2006

Founded

Funded Companies

Company
Description
Industry
Website
Location
SutroVax

An independent vaccine platform in California that focuses on delivering best-in-class conjugate vaccines and complex antigen-based vaccines to prevent deadly infectious diseases.

Antigen
Foster City, California
Xagenic

A molecular diagnostics company that develops testing for infecctious diseases

Biotechnology
Toronto
PHEMI Inc

PHEMI Inc is a Vancouver-based company.

Vancouver
PreciThera

PreciThera is a Canada-based medicine company.

Medicine
Canada
4 Results
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Jean-Francois Leprince

Managing Partner

Janelle Anderson

Managing Partner

Ken Pastor

General Partner

Laurence Rulleau

Partner

Shermaine Tilley

Managing Partner

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

DalCor Pharmaceuticals

ILKOS Therapeutic

CellAegis Devices

IMV Inc

PHEMI Health Systems

PreciThera

SutroVax

Visterra

Visterra

Zymeworks

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.